EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis

Autor: García-Martín, Adela, Garrido-Rodríguez, Martín, Navarrete, Carmen, del Río, Carmen, Bellido, María L., Appendino, Giovanni, Calzado, Marco A., Muñoz, Eduardo
Zdroj: In Biochemical Pharmacology November 2018 157:304-313
Databáze: ScienceDirect